Cite
[Pathogenetic significance of C774T single nucleotide polymorphism of the endothelial NO synthase gene in the development of metabolic syndrome].
MLA
Fattakhov, N. S., et al. “[Pathogenetic Significance of C774T Single Nucleotide Polymorphism of the Endothelial NO Synthase Gene in the Development of Metabolic Syndrome].” Biomeditsinskaia Khimiia, vol. 62, no. 4, May 2016, pp. 447–52. EBSCOhost, https://doi.org/10.18097/PBMC20166204447.
APA
Fattakhov, N. S., Vasilenko, M. A., Skuratovskaia, D. A., Kulikov, D. I., Kirienkova, E. V., Zatolokin, P. A., Beletskaya, M. A., & Litvinova, L. S. (2016). [Pathogenetic significance of C774T single nucleotide polymorphism of the endothelial NO synthase gene in the development of metabolic syndrome]. Biomeditsinskaia Khimiia, 62(4), 447–452. https://doi.org/10.18097/PBMC20166204447
Chicago
Fattakhov, N S, M A Vasilenko, D A Skuratovskaia, D I Kulikov, E V Kirienkova, P A Zatolokin, M A Beletskaya, and L S Litvinova. 2016. “[Pathogenetic Significance of C774T Single Nucleotide Polymorphism of the Endothelial NO Synthase Gene in the Development of Metabolic Syndrome].” Biomeditsinskaia Khimiia 62 (4): 447–52. doi:10.18097/PBMC20166204447.